16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set

      research-article
      , PhD * , , , , PhD * , , MD , , MD § , , MD , , PhD , , MD, PhD # , , MD, MS ** , , MD †† , , MD ‡‡ , , MD §§ , , PhD ∥∥ , ¶¶ , ## , , MPH * , , BS * , , MS * , , MS * , , MS *** , , MD, PhD * , , PhD * , , BS * , , MA * , , BS * , , BS * , * , , BS * , , MS * , , PhD ††† ,   , MD ‡‡‡
      (Collab)
      Alzheimer Disease and Associated Disorders
      Lippincott Williams & Wilkins
      Alzheimer disease center, National Alzheimer’s Coordinating Center, Alzheimer disease, Lewy body disease, frontotemporal degeneration, MCI

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Supplemental Digital Content is available in the text.

          Abstract

          Introduction:

          In 2015, the US Alzheimer’s Disease Centers (ADC) implemented Version 3 of the Uniform Data Set (UDS). This paper describes the history of Version 3 development and the UDS data that are freely available to researchers.

          Methods:

          UDS Version 3 was developed after years of coordination between the National Institute on Aging-appointed Clinical Task Force (CTF), clinicians from ∼30 ADCs, and the National Alzheimer’s Coordinating Center (NACC). The CTF recognized the need for updates to align with the state of the science in dementia research, while being flexible to the diverse needs and diseases studied at the ADCs. Version 3 also developed a nonproprietary neuropsychological battery.

          Results:

          This paper focuses on the substantial Version 3 changes to the UDS forms related to clinical diagnosis and characterization of clinical symptoms to match updated consensus-based diagnostic criteria. Between March 2015 and March 2018, 4820 participants were enrolled using UDS Version 3. Longitudinal data were available for 25,337 of the 37,568 total participants using all UDS versions.

          Discussion:

          The results from utilization of the UDS highlight the possibility for numerous research institutions to successfully collaborate, produce, and use standardized data collection instruments for over a decade.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)

          Introduction: The neuropsychological battery of the Uniform Data Set (UDSNB) was implemented in 2005 by the National Institute on Aging (NIA) Alzheimer Disease Centers program to measure cognitive performance in dementia and mild cognitive impairment due to Alzheimer Disease. This paper describes a revision, the UDSNB 3.0. Methods: The Neuropsychology Work Group of the NIA Clinical Task Force recommended revisions through a process of due diligence to address shortcomings of the original battery. The UDSNB 3.0 covers episodic memory, processing speed, executive function, language, and constructional ability. Data from 3602 cognitively normal participants in the National Alzheimer Coordinating Center database were analyzed. Results: Descriptive statistics are presented. Multivariable linear regression analyses demonstrated score differences by age, sex, and education and were also used to create a normative calculator available online. Discussion: The UDSNB 3.0 neuropsychological battery provides a valuable non proprietary resource for conducting research on cognitive aging and dementia.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses

            Neuropathologic evaluation remains the gold standard for determining the presence and severity of aging-related neurodegenerative diseases. Researchers at U.S. Alzheimer’s Disease Centers (ADCs) have worked for >30 years studying human brains, with the goals of achieving new research breakthroughs. Harmonization and sharing among the 39 current and past ADCs is promoted by the National Alzheimer’s Coordinating Center (NACC), which collects, audits, and disburses ADC-derived data to investigators on request. The past decades have witnessed revised disease definitions paired with dramatic expansion in the granularity and multimodality of the collected data. The NACC database now includes cognitive test scores, comorbidities, drug history, neuroimaging, and links to genomics. Relatively, recent advances in the neuropathologic diagnoses of Alzheimer’s disease, frontotemporal lobar degeneration (FTLD), and vascular contributions to cognitive impairment and dementia catalyzed a 2014 update to the NACC Neuropathology Form completed by all ADCs. New focal points include cerebrovascular disease (including arteriolosclerosis, microbleeds, and microinfarcts), hippocampal sclerosis, TDP-43, and FTLD. Here, we provide summary data and analyses to illustrate the potential for both hypothesis-testing and also generating new hypotheses using the NACC Neuropathology data set, which represents one of the largest multi-center databases of carefully curated neuropathologic information that is freely available to researchers worldwide.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.

              Alzheimer's Disease (AD) can be conceptualized as a continuum: patients progress from normal cognition to mild cognitive impairment (MCI) due to AD, followed by increasing severity of AD dementia. Prior research has measured transition probabilities among later stages of AD, but not for the complete spectrum.
                Bookmark

                Author and article information

                Journal
                Alzheimer Dis Assoc Disord
                Alzheimer Dis Assoc Disord
                WAD
                Alzheimer Disease and Associated Disorders
                Lippincott Williams & Wilkins
                0893-0341
                1546-4156
                Oct-Dec 2018
                29 October 2018
                : 32
                : 4
                : 351-358
                Affiliations
                [* ]Department of Epidemiology, National Alzheimer’s Coordinating Center, University of Washington, Seattle, WA
                []Institute for Healthy Aging and Lifespan Studies and School of Urban and Regional Planning, Florida Atlantic University, Boca Raton, FL
                []Department of Neurology, Mayo Clinic, Rochester, MN
                [§ ]Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles
                []Department of Neurosciences, University of California San Diego, La Jolla, CA
                []Departments of Psychiatry and Neurology, and Cognitive Neurology and Alzheimer’s Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL
                [# ]Department of Neurology, University of Kentucky, Lexington, KY
                [** ]Department of Medicine, University of Wisconsin School of Medicine and Public Health; Geriatric Research, Education and Clinical Center, Madison VA Hospital, Madison, WI
                [†† ]Department of Neurology, School of Medicine, University of Kansas, Kansas City, KS
                [‡‡ ]Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR
                [§§ ]Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
                [∥∥ ]Department of Psychiatry, University of Pittsburgh School of Medicine
                [¶¶ ]Department of Neurology, University of Pittsburgh School of Medicine
                [## ]Mental Illness Research, Education, and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA
                [*** ]Center for Biomedical Statistics, University of Washington, Seattle, WA
                [††† ]National Institute on Aging (retired), Bethesda, MD
                [‡‡‡ ]Department of Neurology, Washington University School of Medicine, St. Louis, MO
                Author notes
                Reprints: Lilah Besser, PhD, School of Urban and Regional Planning, College of Design and Social Inquiry, Florida Atlantic University, SO 44, 777 Glades Rd., Boca Raton, FL 33431 (e-mail: lbesser@ 123456fau.edu ).
                Article
                00015
                10.1097/WAD.0000000000000279
                6249084
                30376508
                7b9c4908-1460-4551-8864-e7247b3c8572
                Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/

                History
                : 5 July 2018
                : 4 September 2018
                Categories
                Review Article
                Custom metadata
                T
                TRUE

                alzheimer disease center,national alzheimer’s coordinating center,alzheimer disease,lewy body disease,frontotemporal degeneration,mci

                Comments

                Comment on this article